Cardiac risk and perioperative management

Journal of Cardiovascular Surgery

Volumn 44, Issue 3, 2003, Pages 431-435

  Kertai, M D ^a   Poldermans, D ^a   Bax, J J ^a   Klein, J ^a   van Urk, H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Coronary disease, diagnosis; Risk factors; Vascular surgical procedures

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICOAGULANT AGENT; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; DILTIAZEM; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; MIVAZEROL;

ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLAUDICATION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; DRUG EFFICACY; EXERCISE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HUMAN; LONGITUDINAL STUDY; MORBIDITY; PATIENT CARE; PERIOPERATIVE PERIOD; PHYSICIAN; PREOPERATIVE EVALUATION; STROKE; SURGICAL MORTALITY; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANTICHOLESTEREMIC AGENTS; CAUSE OF DEATH; CORONARY DISEASE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYOCARDIAL REVASCULARIZATION; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; VASCULAR SURGICAL PROCEDURES;

EID: 0042200258     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Konings-Dalstra JAA, Reitsma JB. Hart- en vaatziekten in Nederland 1999, cijfers over ziekte ensterfte. Den Haag: Nederlandse Hartstichting; 1999.
2. Mangano DT. Perioperative cardiac morbidity. Anaesthesiology 1990;72:153-84.
3. Cohen MC, Aretz TH. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol 1999;8:133-9.
4. Dawood MM, Gutpa DK, Southern J, Walia A, Atkinson JB, Eagle KM. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol 1996;57:37-44.
5. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002;105: 1257-67.
6. Poldermans D, Arnese M, Fioretti PM, Salustri A, Boersma E, Thomson IR et al. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. J Am Coll Cardiol 1995;26:648-53.
7. Boersma E, Poldermans D, Bax JJ, Steyerberg EW, Thomson IR, Banga JD et al. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 2001;285:1865-73.
8. Kertai MD, Boersma E, Bax JJ, Heijenbroek-Kal MH, Hunink M, Steyerherg EW et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for prediction perioperative cardiac risk in patients undergoing major vascular surgery. Heart. In press 2003.
9. Poldermans D, Fioretti PM, Forster T, Thomson IR, Boersma E, el-Said EM et al. Dobutamine stress echocardiography for the assessment of perioperative cardiac risk in patients undergoing major non cardiac vascular surgery. Circulation 1993;87:1506-12.
10. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996;335:1713-20.
11. Poldermans D, Boersma E, Bax JJ, Thomson IR, Van de Ven L, Blankensteijn JD et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999;341:1789-94.
12. Stone JG, Foex P, Sear JW, Johnson LL, Khambatta HJ, Triner L. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a β-adrenergic blocking agent. Anesthesiology 1988;68:495-500.
13. Wallace A, Layug B, Tateo I, Li J, Hollenberg M, Browner W et al. Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology 1998;88:7-17.
14. Ellis JE, Drijvers G, Pedlow S, Laff SP, Sorrentino MJ, Foss JF et al. Premedication with oral and transdermal clonidine provides sale and efficacious postoperative sympatholysis. Anesth Analg 1994;79:1133-40.
15. Stuhmeier KD, Mainzer B, Cierpka J, Sandman W, Tarnow J. Small, oral dose of clonidine reduces the incidence of intraoperative myocardial ischemia in patients having vascular surgery. Anesthesiology 1996;85:706-12.
16. Oliver MF, Goldman L, Julian DG, Holme I. Effect of mivazerol on perioperative cardiac complications during noncardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology 1999;91:951-61.
17. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 2001;21:1712-9.
18. Huhle G, Abletshauser C, Mayer N, Weidinger G, Harenberg J, Heene DL. Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor. Thromb Res 1999;95:229-34.
19. Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J, Sanchez-Pascuala R, Hernandez G, Diaz C et al. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 1998;101:2711-9.
20. Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 1994;89:2035-40.
21. Kurowska EM. Nitric oxide therapies in vascular diseases. Curr Pharm Des 2002;8:155-66.
22. van Haelst PL, van Doormaal JJ, May JF, Gans RO, Crijns HJ, Cohen Tervaert JW. Secondary prevention with fluvastatin decreases levels of adhesion molecules, neopterin and C-reactive protein. Eur J Intern Med 2001;12:503-9.
23. Poldermans D, Bax JJ, Kertai MD, Krenning B, Westerhout CM, Schinkel AF et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003;107:1848-51.
24. Durazzo AE, Machado FS, Ikeoka D, Puech-Leao P, Caramelli B. Effect of atorvastatin on cardiovascular events after vascular surgery. Circulation 2002;106 Supplement II:II-343
25. Coriat P, Daloz M, Bousseau D, Fuscuardi J, Echter E, Viars P. Prevention of intraoperative myocardial ischemia during noncardiac surgery with intravenous nitroglycerin. Anesthesiology 1984;61: 193-6.
26. Godet G, Coriat P, Baron JF, Bertrand M, Diquet B, Sebag C et al. Prevention of intraoperative myocardial ischemia during noncardiac surgery with intravenous diltiazem: a randomised trial versus placebo. Anesthesiology 1987;66:241-5.
27. Gottlieb A, Banoub M, Sprung J, Levy PJ, Beven M, Mascha EJ. Perioperative cardiovascular morbidity in patients with coronary artery disease undergoing vascular surgery after percutaneous transluminal coronary angioplasty. J Cardiothorac Vasc Anesth 1998;12:501-6.
28. Allen JR, Helling TS, Hartzler GO. Operative procedures not involving the heart after percutaneous transluminal coronary angioplasty. Surg Gynecol Obstet 1991;173:285-8.
29. Elmore JR, Hallett JW Jr, Gibbons RJ, Naessens JM, Bower TC, Cherry KJ et al. Myocardial revascularization before abdominal aortic aneurysmorrhaphy: effect of coronary angioplasty. Mayo Clin Proc 1993;68:637-41.
30. Posner KL, van Norman GA, Chan V, Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty. Anesth Analg 1999;89:553-60.
31. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Ain Coll Cardiol 2000;35:1288-94.
32. Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. Circulation 1997;96: 1882-7.
33. Fleisher LA, Eagle KA, Shaffer T, Anderson GF. Perioperative- and long-term mortality rates after major vascular surgery: the relationship to preoperative testing in the Medicare population. Anesth Analg 1999;89:849-55.
34. Hassan SA, Hlatky MA, Boothroyd DB, Winston C, Mark DB, Brooks MM et al. Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Med 2001;110:260-6.